SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-013027
Filing Date
2021-03-15
Accepted
2021-03-15 09:11:39
Documents
75
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clsd-10k_20201231.htm 10-K 2654767
2 EX-23.1 clsd-ex231_7.htm EX-23.1 12658
3 EX-31.1 clsd-ex311_12.htm EX-31.1 19993
4 EX-31.2 clsd-ex312_15.htm EX-31.2 19956
5 EX-32.1 clsd-ex321_10.htm EX-32.1 9540
6 EX-99.1 clsd-ex991_488.htm EX-99.1 30703
7 GRAPHIC grwxwuxwwih5000002.jpg GRAPHIC 115374
8 GRAPHIC grwxwuxwwih5000003.jpg GRAPHIC 170967
9 GRAPHIC grwxwuxwwih5000001.jpg GRAPHIC 53301
  Complete submission text file 0001564590-21-013027.txt   8944560

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT clsd-20201231.xml EX-101.INS 1733434
11 XBRL TAXONOMY EXTENSION SCHEMA clsd-20201231.xsd EX-101.SCH 56906
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsd-20201231_cal.xml EX-101.CAL 49702
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsd-20201231_def.xml EX-101.DEF 208920
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20201231_lab.xml EX-101.LAB 472696
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20201231_pre.xml EX-101.PRE 356908
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37783 | Film No.: 21740018
SIC: 2834 Pharmaceutical Preparations